BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19507208)

  • 1. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
    Ling HT; Field JJ; Blinder MA
    Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.
    Elliott MA; Heit JA; Pruthi RK; Gastineau DA; Winters JL; Hook CC
    Eur J Haematol; 2009 Oct; 83(4):365-72. PubMed ID: 19508684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM; Uener J; Hallek M; Scheid C
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
    Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
    Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S; Matsumoto M; Ohtani Y; Take H; Ishizashi H; Fujimura Y; Kuyama J
    Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
    Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
    Jayabose S; Dunbar J; Nowicki TS; Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y
    Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.
    Harambat J; Lamireau D; Delmas Y; Ryman A; Llanas B; Brissaud O
    Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment.
    Kameda T; Dobashi H; Kittaka K; Susaki K; Yamaoka G; Arai K; Tokuda M; Ishida T
    Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
    Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA
    Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
    Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J; Adamski J; Lima JL; Marques MB
    J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
    Bhagirath VC; Kelton JG; Moore J; Arnold DM
    Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
    Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R
    Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.